ArticleFrontiers in cardiovascular medicine2022

Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.

Wanqian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.